Here you will find case studies showing how pharma and medcomms teams are using EveryView in practice.
Alongside some perspectives from the EveryView team on the way expert insight gets gathered, tested and recorded.
Evidence: Client Case Studies
Baxter.
Pharmaceuticals by Baxter's European Medical Affairs team replaced anecdote and one-off surveys with an ongoing, multilingual insight programme across international practitioner cohorts.
Merz Therapeutics used EveryView before, during and after the rollout of a digital spasticity support tool, embedding structured clinician feedback into every stage of development.
A large Medical Communications agency uses EveryView as the final validation stage of its expert consensus programmes, replacing face-to-face meetings and email chains with structured voting, full audit trails and defensible outcomes for its pharma clients.
Our thoughts on where insight, consensus and product feedback are heading.
Consensus meetings need a rethink... and an upgrade.
Most roundtables end with everyone believing they've reached alignment, and no way to prove it. Why real consensus needs to be tested, measured and recorded, not assumed.
Why most pulse surveys fail to change anything, and what separates a real insight programme from a series of one-off snapshots that never inform a decision.
